Literature DB >> 2795713

Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics.

Y Kawaoka1, S Krauss, R G Webster.   

Abstract

We determined the origin and evolutionary pathways of the PB1 genes of influenza A viruses responsible for the 1957 and 1968 human pandemics and obtained information on the variable or conserved region of the PB1 protein. The evolutionary tree constructed from nucleotide sequences suggested the following: (i) the PB1 gene of the 1957 human pandemic strain, A/Singapore/1/57 (H2N2), was probably introduced from avian species and was maintained in humans until 1968; (ii) in the 1968 pandemic strain, A/NT/60/68 (H3N2), the PB1 gene was not derived from the previously circulating virus in humans but probably from another avian virus; and (iii) a current human H3N2 virus inherited the PB1 gene from an A/NT/60/68-like virus. Nucleotide sequence analysis also showed that the avian PB1 gene was introduced into pigs. Hence, transmission of the PB1 gene from avian to mammalian species is a relatively frequent event. Comparative analysis of deduced amino acid sequences disclosed highly conserved regions in PB1 proteins, which may be key structures required for PB1 activities.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2795713      PMCID: PMC251093     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  A sequence motif in many polymerases.

Authors:  P Argos
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

2.  The origin of pandemic influenza.

Authors:  R G Webster; W G Laver
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

Review 3.  Influenza A viruses: combinations of hemagglutinin and neuraminidase subtypes isolated from animals and other sources.

Authors:  V S Hinshaw; R G Webster; R J Rodriguez
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

4.  Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).

Authors:  N J Cox; F Kitame; A P Kendal; H F Maassab; C Naeve
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

5.  The sequence of the nucleoprotein gene of human influenza A virus, strain A/NT/60/68.

Authors:  J A Huddleston; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1982-02-11       Impact factor: 16.971

6.  The complete sequence of RNA segment 2 of influenza A/NT/60/68 P1 protein.

Authors:  D H Bishop; J A Huddleston; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1982-02-25       Impact factor: 16.971

7.  Electrophoretic analysis of iodine-labeled influenza virus RNA segments.

Authors:  W J Bean; G Sriram; R G Webster
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

8.  Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription.

Authors:  I Ulmanen; B A Broni; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus.

Authors:  G M Air
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

10.  Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer.

Authors:  G I Shapiro; R M Krug
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more
  332 in total

Review 1.  The evolution of human influenza viruses.

Authors:  A J Hay; V Gregory; A R Douglas; Y P Lin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82.

Authors:  Irina V Alymova; Amanda M Green; Nicholas van de Velde; Julie L McAuley; Kelli L Boyd; Hazem E Ghoneim; Jonathan A McCullers
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 3.  The contribution of animal models to the understanding of the host range and virulence of influenza A viruses.

Authors:  Christopher D O'Donnell; Kanta Subbarao
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

4.  Sialic acid species as a determinant of the host range of influenza A viruses.

Authors:  Y Suzuki; T Ito; T Suzuki; R E Holland; T M Chambers; M Kiso; H Ishida; Y Kawaoka
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Influenza viruses: structure and interspecies transmission mechanisms.

Authors:  I Donatelli; L Campitelli; S Puzelli; C Affinito; M A De Marco; M Delogu; G Barigazzi
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

Review 6.  Influenza: emergence and control.

Authors:  Aleksandr S Lipatov; Elena A Govorkova; Richard J Webby; Hiroichi Ozaki; Malik Peiris; Yi Guan; Leo Poon; Robert G Webster
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 7.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

Review 8.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

9.  Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence.

Authors:  Gongxun Zhong; Mai Quynh Le; Tiago J S Lopes; Peter Halfmann; Masato Hatta; Shufang Fan; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

10.  Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes.

Authors:  Tokiko Watanabe; Shinji Watanabe; Takeshi Noda; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.